Skip to main content
. 2015 Feb 4;9:225–233. doi: 10.2147/OPTH.S76847

Figure 3.

Figure 3

Changes in the percentage of patients without metamorphopsia and the mean metamorphopsia scores.

Notes: The percentage of patients without metamorphopsia increased as the metamorphopsia scores decreased until finally 35.4% of patients had no metamorphopsia in their daily life at 12 months. Error bars indicate standard error. *,†Statistically significant compared with the metamorphopsia score at baseline (P<0.001), n=65.

Abbreviations: MV, metamorphopsia for vertical lines; MH, metamorphopsia for horizontal lines.